These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metastatic carcinoid tumor of the prostate. Tash JA; Reuter V; Russo P J Urol; 2002 Jun; 167(6):2526-7. PubMed ID: 11992077 [No Abstract] [Full Text] [Related]
4. [Flush-syndrome without flush--rectal carcinoid tumor as an accidental finding]. Schmidt CW; Mende W Z Arztl Fortbild (Jena); 1986; 80(4):161-2. PubMed ID: 3716467 [No Abstract] [Full Text] [Related]
8. Neuroendocrine carcinoma of the prostate gland: authors' reply. Zarkovic A; Masters J; Carpenter L Pathology; 2005 Dec; 37(6):568. PubMed ID: 16373241 [No Abstract] [Full Text] [Related]
9. Editorial comment on: Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Seitz M; Gratzke C Eur Urol; 2009 Mar; 55(3):591. PubMed ID: 18952366 [No Abstract] [Full Text] [Related]
10. The role of imaging in the oncological prostate. Chabanova E; Lögager VB Acta Radiol; 2008 Feb; 49(1):4. PubMed ID: 18210305 [No Abstract] [Full Text] [Related]
11. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer. Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548 [TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging. Macura KJ Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034 [No Abstract] [Full Text] [Related]
14. Primary hepatic carcinoid tumour: a detailed account of imaging findings. Yeung YP; Sau S; Chiu H; Chong KA; Li VK Hepatogastroenterology; 2008; 55(82-83):663-5. PubMed ID: 18613428 [TBL] [Abstract][Full Text] [Related]
15. [Primary carcinoid tumor of the prostate (report of a case) (author's transl)]. Miki T; Kuroda M; Kiyohara H; Usami M; Nakamura T; Kotake T Nihon Hinyokika Gakkai Zasshi; 1980; 71(3):264-72. PubMed ID: 7392346 [No Abstract] [Full Text] [Related]
16. Secondary cancers after a lung carcinoid primary: a population-based analysis. Cote ML; Wenzlaff AS; Philip PA; Schwartz AG Lung Cancer; 2006 Jun; 52(3):273-9. PubMed ID: 16567020 [TBL] [Abstract][Full Text] [Related]
18. GI carcinoid tumours: appearance of the primary and detecting metastases. Gore RM; Berlin JW; Mehta UK; Newmark GM; Yaghmai V Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):245-63. PubMed ID: 15763699 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer. Huzjan R; Sala E; Hricak H Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681 [TBL] [Abstract][Full Text] [Related]